title: GAPO syndrome associated with pyoderma vegetans: an unreported co-existence.
abstract: GAPO syndrome is a rare autosomal recessive disease and an acronym composed of growth retardation, alopecia, pseudoanodontia, optic atrophy. Approximately 38 cases have been reported in literature until now. Pyoderma vegetans is a chronic inflammatory disease characterized with vesicopustular, exudative and vegetative lesions usually localized on face, scalp, axilla and genitalia. Pyoderma vegetans is attributed to a bacterial infection frequently occurring in individuals with an underlying immunosuppressive condition. A 30-year-old female patient was admitted to our clinic with complaint of a hemorrhagic, crusted, exudative vegetative two plaques on the scalp. On her physical examination, she had a prematurely aged face, predominant lower lips, total tooth loss, frontal bossing, enlarged anterior fontanelle, marked scalp veins, micrognatia, depressed nasal bridge, short stature, growth retardation. She was diagnosed as GAPO syndrome as the result of her physical examination. Result of the biopsy taken from scalp was evaluated as pyoderma vegetans. And the diagnosis of pyoderma vegetans was established based on the correlate of both clinical and histopathologic findings. Pyoderma vegetans coexisting with GAPO syndrome has not been reported previously. Thus we wished to report it.
authors.affiliation: Department of Dermatology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey. karadagaserap@gmail.com
authors.forename: A S
authors.initials: AS
authors.lastname: Karadag
authors.forename: O
authors.initials: O
authors.lastname: Calka
authors.forename: S G
authors.initials: SG
authors.lastname: Bilgili
authors.forename: R
authors.initials: R
authors.lastname: Karadag
authors.forename: G
authors.initials: G
authors.lastname: Bulut
mesh_terms: D000328:Adult; D000505:Alopecia / Q000175:diagnosis* / Q000453:epidemiology; D000848:Anodontia / Q000175:diagnosis* / Q000453:epidemiology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002506:Cephalexin / Q000008:administration & dosage; D015897:Comorbidity; D005260:Female; D006130:Growth Disorders / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D015418:Optic Atrophies, Hereditary / Q000175:diagnosis* / Q000453:epidemiology; D011711:Pyoderma / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002506:Cephalexin